JONATHAN YEH: Open Payments
NPI 1457667024 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,658 in 111 payments from 11 companies in 2025. Trend: 2023 $2,653 · 2024 $18,942 · 2025 $32,658
Speaker / faculty: $22,005Travel & lodging: $3,960Consulting: $3,611Food & beverage: $3,082
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 78 | $26,901 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $4,145 |
| Novo Nordisk Inc | 2 | $870 |
| Ipsen Biopharmaceuticals, Inc | 2 | $233 |
| Gilead Sciences, Inc. | 10 | $211 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Davol Inc. | 1 | $67 |
| Intra-Sana Laboratories | 2 | $47 |
| ORPHALAN INC | 1 | $23 |
| Amgen Inc. | 1 | $22 |
Products named: REZDIFFRA, TRULANCE, IQIRVO, ARISTA, XIFAXAN, RELTONE 200 MG, CUVRIOR, Livmarli.
Industry payments across NY — which companies pay providers there.
